Join the club for FREE to access the whole archive and other member benefits.

Garri Zmudze

Managing Partner at LongeVC, Advising the pioneers of next-gen medicine, breakthrough biotech and accessible longevity

Garri is a seasoned business angel with an extensive track record in tech business and an early investor in science-intensive ventures, such as Insilico Medicine and Basepaws. Prior to founding LongeVC, he co-founded Longenesis — a medical technology startup company working towards providing a technological bridge between Healthcare institutions and the BioTech industry with an aim to help identify and unlock the hidden value of biomedical data to accelerate the novel drug and treatment discovery and provide better help to those in need. In 2021, Garri became the Executive Coordinator of Longevity Science Foundation — a Swiss non-profit organisation advancing human longevity by funding research and development of medical technologies to extend the healthy human lifespan to more than 120 years.

Visit website: https://garrizmudze.com/

 garri-zmudze-982a48138

See also: Company LongeVC - Company supporting early-stage biotech and longevity-focused founders

Details last updated 13-Nov-2021

Garri Zmudze is also referenced in the following:

ARDD 2023 - 10th Aging Research & Drug Discovery Meeting

28-Aug-2023 to 01-Sep-2023

Event about latest progress in the molecular, cellular and organismal basis of aging organized by University of Copenhagen

Innovations in Consumer Longevity Data: A Global Perspective

19-Nov-2021

Ageing Research at King's (ARK) Longevity Week 2021 Event (FREE)